IDEAYA Biosciences logo
IDEAYA Biosciences IDYA
$ 25.95 4.68%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

IDEAYA Biosciences Financial Statements 2011-2024 | IDYA

Annual Financial Statements IDEAYA Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.51 B 746 M 584 M 435 M 107 M - - - - - - - -

Shares

57.5 M 41.4 M 35.3 M 24.7 M 12.5 M - - - - - - - -

Historical Prices

43.7 18 16.6 17.6 8.55 - - - - - - - -

Net Income

-113 M -58.7 M -49.8 M -34.5 M -42 M -34.3 M -11.9 M - - - - - -

Revenue

23.4 M 50.9 M 27.9 M 19.5 M - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-134 M -62.5 M -50.3 M -35.3 M -44.3 M -36.4 M -14.4 M - - - - - -

Interest Expense

- - - - 8 K 77 K 2.43 M - - - - - -

EBITDA

-132 M -60.4 M -48.5 M -34 M -43 M -35.5 M -14 M - - - - - -

Operating Expenses

158 M 113 M 78.2 M 54.9 M 44.3 M - - - - - - - -

General and Administrative Expenses

28.3 M 23.9 M 20.1 M 15.2 M 9.95 M 4.67 M 2.05 M - - - - - -

All numbers in USD currency

Quarterly Income Statement IDEAYA Biosciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

86.2 M 78 M 75.1 M 65 M 60 M 56.3 M 48.4 M 48.2 M 40.3 M 38.7 M 38.6 M 38.5 M 37.8 M 32.9 M 31.8 M 29.5 M 28.4 M 21 M 20.3 M 20.3 M 20.2 M 8.22 M 1.1 M 1.34 M 999 K 936 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-51.8 M -52.8 M -39.6 M - -27.4 M -27.9 M -23.6 M - 1.62 M -22.1 M -14 M - -11.6 M -10.9 M -9.02 M - -4.93 M -12.4 M -12 M -10.8 M -11 M -10.7 M -9.57 M -8.56 M -13.1 M -7 M -5.74 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - 8.04 M 3.54 M 7.88 M - 29.7 M 5.85 M 11.4 M - 8.98 M 8.76 M 7.25 M - 8.97 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-66.9 M -64.9 M -51 M - -33.5 M -32.7 M -26.3 M - 660 K -22.5 M -14.2 M - -11.7 M -11.1 M -9.14 M - -5 M -12.6 M -12.5 M - -11.6 M -11.2 M -10.1 M - -13.6 M -7.57 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - 6 K - - 1 K 8 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-66.3 M -64.3 M -50.4 M - -32.9 M -32.1 M -25.7 M - 1.26 M -22 M -13.8 M - -10.4 M -10.2 M -8.75 M - -3.98 M -11.9 M -12.1 M - -10.7 M -10.6 M -9.8 M - -13 M -7.17 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

66.9 M 64.9 M 51 M - 41.6 M 36.3 M 34.2 M - 29 M 28.4 M 25.6 M - 20.7 M 19.8 M 16.4 M - 14 M 12.6 M 12.5 M 11.3 M 11.6 M 11.2 M 10.1 M 9.13 M 13.6 M 7.57 M 6.09 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

9.74 M 10.4 M 8.21 M - 7.86 M 7.08 M 6.3 M - 6.67 M 5.55 M 5.92 M - 5.19 M 4.83 M 4.82 M - 3.94 M 3.99 M 3.45 M - 2.7 M 2.38 M 2.1 M - 1.09 M 1.14 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency